Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunpeaks Ventures, Inc. (OTCBB: SNPK) Featured By Small Cap Investment Research

(EMAILWIRE.COM, April 11, 2012 ) Los Angeles, CA -- Small Cap Investment Research (SmallCapInvestmentResearch.com), a developer, publisher and marketer of independent research products, announced today the release of an updated research report on Sunpeaks Ventures, Inc (OTCBB: SNPK) (“the Company”). Small Cap Investment Research has issued a “STRONG BUY” and a target price of $9.00 on shares of this company.



The report examines the potential continued growth of the Company as it continues to gain market share, and examines the outlook for short and long-term investors. “We were pleased to have the opportunity to report on this company and the industry factors that affect it. The report presents a great overview of the Company and its potential for the long-term with a constantly improving industry dynamic.” – Small Cap Investment Research.



Recently, Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") announced that HDS has signed a Letter of Intent with PharmaLife® for placement of Clotamin® with leading pharmacies in the Russian Federation.



The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

The entire report can be found on http://www.smallcapinvestmentresearch.com/featured-companies/ .



About Small Cap Investment Research:

Small Cap Investment Research specializes in providing readers with an in-depth analysis of undervalued companies. The company’s role as an independent research analyst firm is to “separate the wheat from the chaff” and help investors receive unbiased, thought-provoking, and quality investment research. SCIR’s philosophy in research is to encapsulate realistic investment ratings, target prices, and forward-looking financial models. The reports contain hard-hitting, meticulously researched facts on companies, their fundamentals, and their industries, validating a company’s prospects and enabling the reader to objectively evaluate the company’s value. The media and savvy investors alike view this model as how investment research needs to be performed devoid of any partiality.



About Sunpeaks Ventures, Inc.:

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.



Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Sunpeaks Ventures, Inc. (OTCBB: SNPK) can be found in the filings of Sunpeaks Ventures, Inc. with the U.S. Securities and Exchange Commission.



Release of Liability: Through use of this website viewing or using you agree to hold SCIR, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We have been compensated six thousand dollars for this SNPK report. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCIR encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCIR makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.



Indepedent Research Investment
Derrick Brazinski
3104567798
dbrazinski@indedentresearchinvestment.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Spain orders custody for parents of ill UK boy
1 Sep 2014 at 6:28am

LONDON (AP) ? The grandmother of a 5-year-old British boy with a severe brain tumor accused U.K. authorities on Monday of cruelty for seeking an arrest warrant and pursuing the family abroad after his parents removed him from a British hospital against medical advice.


India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
1 Sep 2014 at 6:14am
India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under the name Serrofloin in Germany and Salmeterol/Fluticasone Cipla in Sweden, the Mumbai-based company said in a statement on Monday. In December, Denmark became the first European country to approve for sale a generic version of GlaxoSmithKline's $8 billion-a-year Advair, and analysts have been expecting more such approvals.


Novartis Japan admits concealing drug side effects
1 Sep 2014 at 6:13am

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities. The revelations, which marked the latest in a string of scandals at the company's Japanese subsidiary, come after local authorities slapped the firm on the wrist, saying it had to clean up its operations. On Friday, Novartis issued a statement saying it had failed to report to regulators at least 2,579 cases where patients had suffered serious potential side effects from its drugs. Japan's Jiji Press news agency said they included some fatal cases, without specifying a figure.



Tests show no sign of Ebola in Swedish man
1 Sep 2014 at 2:46am

Medical authorities in the Swedish capital said on Monday tests on a man brought into hospital over the weekend and suspected of potentially carrying Ebola showed no signs the deadly disease. The Swedish man, whose name was not disclosed, had recently traveled to a "risk area" for the virus and had been taken to the Karolinska University Hospital in Stockholm suffering from a fever, sparking suspicions of Ebola. Stockholm county council said in a statement the man would continue to be treated at the hospital to ascertain the cause of his symptoms. More than 1,500 people have died in an Ebola outbreak in West Africa since March.



'Most exciting ever' Novartis drug points to huge sales
1 Sep 2014 at 2:21am

By Ben Hirschler BARCELONA (Reuters) - Sales forecasts for Novartis's new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease. David Epstein, Novartis' head of pharmaceuticals, said the launch of the drug next year promised to be the company's most exciting ever and profit margins on the medicine would be good. The results of a keenly-awaited clinical trial on LCZ696 were released at the annual meeting of the European Society of Cardiology on Saturday and published in the New England Journal of Medicine with a glowing editorial. Investigators working on the study and the company itself believe it has potential to replace drugs that have been central to treating heart failure for a quarter of century, opening up a multi-billion dollar sales opportunity.


Cyberonics device improves heart function after Boston flop
1 Sep 2014 at 12:35am
By Ben Hirschler BARCELONA (Reuters) - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific. Both companies are trying to improve outcomes for patients with heart failure, in which the heart fails to pump blood efficiently, by stimulating the vagus nerve ? a superhighway connecting the brain to the rest of the body. Vagus nerve stimulation (VNS), which involves delivering mild electrical pulses to the nerve in the neck, is already used successfully to treat severe epilepsy and treatment-resistant depression.

Swedish hospital investigating possible case of Ebola: media
1 Sep 2014 at 12:09am
STOCKHOLM (Reuters) - A hospital in the Swedish capital is investigating a possible case of Ebola, Swedish media reported on Sunday. A man who recently travelled to a "risk area" for the virus was taken to Karolinska University Hospital in Stockholm suffering from a fever and is being treated in an isolation unit, the reports said. More than 1,500 people have died in an Ebola outbreak in West Africa since March. ...


Dengue outbreak affects at least 22 in Japan
31 Aug 2014 at 11:56pm

An outbreak of dengue fever in Japan -- the first since World War II -- has affected at least 22 people, the government said Monday, with all cases believed to be linked to a Tokyo park. The health ministry said 19 new infections have been confirmed since last week. All are believed to have visited Tokyo's Yoyogi Park or its environs, one of the major green lungs of the metropolis, popular with residents and tourists alike. The park, one of the largest open spaces in central Tokyo, is believed to be the source of the mosquito-borne disease.



Judge temporarily blocks law that could close all Louisiana abortion clinics
31 Aug 2014 at 8:48pm

The measure, signed into law by Louisiana Governor Bobby Jindal in June and due to take effect Sept. 1, would require doctors who perform abortions to have patient admitting privileges at a hospital within 30 miles of their practice. "Plaintiffs will be allowed to operate lawfully while continuing their efforts to obtain privileges," Federal Judge John deGravelles wrote in the decision. Abortion rights activists applauded the decision, the latest in a string of rulings against similar measures, saying it would give doctors more time to seek hospital privileges. "Today?s ruling ensures Louisiana women are safe from an underhanded law that seeks to strip them of their health and rights," said Nancy Northup, president and chief executive of the Center for Reproductive Rights, which sued to block the law on behalf of three of the state's five clinics.



Dozens arrested at Made in America music festival in Los Angeles
31 Aug 2014 at 8:31pm

(Reuters) - Seven people were arrested on Sunday at the Made in America music festival in downtown Los Angeles, following an opening day that left more than two dozen people in handcuffs, police said. During Sunday's show at Grand Park there were four felony arrests, including one for battery and the rest for possession of narcotics, besides three misdemeanor arrests, including one charge of public drunkenness, the Los Angeles Police Department said. Another 23 people were given alcohol citations, an LAPD police spokeswoman said. So far about 27,000 tickets have been scanned for Sunday's full day of events, including top-billed stars John Mayer and Kanye West later in the evening.


Health workers death toll mounts in W.Africa as Ebola spreads
31 Aug 2014 at 8:09pm
Nigeria's health minister will hold an emergency meeting of state health commissioners on Monday as West Africa struggles to halt the deadly Ebola virus, amid growing concern at the toll among healthcare workers. Nigeria on Sunday confirmed a fresh case of Ebola in a doctor whose husband died from the virus, adding to a growing list of those providing healthcare in West Africa to be hit by the epidemic. The woman's husband was also a doctor who died in the city of Port Harcourt on August 22 after treating a patient who had contact with the Liberian man who brought the virus to Nigeria in late July. She was in a stable condition at an isolation unit in the financial capital, Lagos, said Sampson Parker, the health commissioner of Rivers State, of which Port Harcourt is the capital.


New test fast-tracks diagnosis for malaria
31 Aug 2014 at 6:28pm

A new invention can cheaply and accurately diagnose malaria infection in just a few minutes using only a droplet of blood, researchers have reported in the journal Nature Medicine. The tool could replace the laborious, error-prone method by which a lab technician looks for malaria parasites in blood through a microscope, they said. While that method is considered the gold standard in malaria diagnostics today, it depends on the technician's skill in interpreting the image, the quality of the microscope and lab chemicals and even on the thickness of the blood smear on the slide itself. The touted replacement is an "inexpensive" desk-top mini-lab that, according to its inventors, can detect fewer than 10 malaria parasites per microlitre of blood, using a sample of less than 10 microlitres -- equivalent to a small drop from a finger prick.


Four members of suburban Chicago family found shot to death
31 Aug 2014 at 2:49pm
By Mary Wisniewski CHICAGO (Reuters) - Four members of a suburban Chicago family were found shot dead in their home, with one death ruled a suicide and the rest homicides, police and coroner officials said on Sunday. Local media said the victims were an elderly couple and their two severely disabled adult children. Police said they were investigating the incident in Elmhurst, about 18 miles west of Chicago, but there was no threat or danger to others. The four bodies were discovered Saturday evening after Elmhurst police went to the home for a "well being check," police said.


WHO: Senegal Ebola case 'a top priority emergency'
31 Aug 2014 at 1:30pm

DAKAR, Senegal (AP) ? The effort to contain Ebola in Senegal is "a top priority emergency," the World Health Organization said Sunday, as the government continued tracing everyone who came in contact with a Guinean student who has tested positive for the deadly disease in the capital, Dakar.



Sweden discovers suspected case of Ebola: official
31 Aug 2014 at 1:10pm

A suspected case of the Ebola virus has been discovered in the Swedish capital Stockholm, a local official told AFP on Sunday. Aake Oertsqvist, a specialist in infection control responsible for the Stockholm area, was quoted as saying the risk of an Ebola outbreak in Sweden was "very low".


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC